FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...